mRNA-based therapies: current progress and future prospects for treating kidney disease.

Area of Science:

• Nephrology
• Molecular Biology
• Biotechnology

Background:

• Chronic kidney disease (CKD) affects millions globally, with increasing incidence and limited treatment efficacy.
• Current treatments often lead to kidney replacement therapy, highlighting the need for novel therapeutic approaches.
• Messenger RNA (mRNA) technology has emerged as a powerful tool in molecular therapy with potential clinical applications.

Purpose of the Study:

• To review recent advancements in mRNA-based therapies for kidney diseases.
• To discuss the future potential of mRNA applications in treating renal conditions.
• To provide an overview of the evolving landscape of mRNA in nephrology.

Main Methods:

• Literature review of recent studies on renal mRNA-based therapies.
• Analysis of emerging trends and future directions in the field.
• Synthesis of current knowledge on mRNA applications in kidney disease.

Main Results:

• mRNA-based therapies are beginning to show promise in the kidney field.
• Recent advances highlight the potential of mRNA for treating various renal pathologies.
• The review consolidates current understanding and future prospects of mRNA in nephrology.

Conclusions:

• mRNA-based therapies represent a significant advancement in the treatment of kidney diseases.
• Further research and development hold promise for novel mRNA-driven interventions.
• mRNA technology offers a potential paradigm shift in managing chronic kidney disease.